Life sciences industry leaders form Microbiome Insights’ inaugural board of directors

MAY 30, 2015 — Microbiome Insights, Inc. is pleased to announce the members of its inaugural Board of Directors (BOD). The members bring with them a wealth of knowledge from the global life sciences industry. Each one has achieved success in academic and/or industry roles and has contributed to groundbreaking advancements in their respective disciplines.

The members are:

Pieter Cullis, PhD, Director at the Life Sciences Institute, University of British Columbia.

Dr. Pieter Cullis brings decades of experience in research and business. He is, along with his colleagues in academia, responsible for many fundamental advances in the field of lipid nanoparticle systems for intravenous delivery of small molecule and macromolecular drugs. This work has led to three products which have been approved by regulatory agencies in the US and Europe, and a further five that have finished Phase 1 trials. Outside of his academic achievements, Dr. Cullis co-founded several biotech companies and has received many distinguished awards, including election to the Royal Society of Canada in 2004.

Brad Popovich, PhD, former Chief Scientific Officer at Genome BC

Dr. Brad Popovich has long been involved with Genome BC, serving on its Board of Directors from 2006-2011 and acting as the Chair for the Scientific Committee from 2008-2010. Alongside his current roles with Genome BC he serves as Chairman for the Genetic Information Management Systems and Director of the Centre for Drug Research and Development Ventures and Centre for Drug Development. His genetics expertise is in genetic counselling; he graduated with Masters degrees in genetic counselling and biochemical genetics, and was awarded a PhD in molecular genetics from McGill University. He also received postdoctoral training and a clinical fellowship in the lab of Nobel Laureate Oliver Smithies. Throughout his career, Dr. Popvich has held many titles as Director, Vice-President, and CEO of numerous companies and academic institutions—including founder and director of the Molecular Diagnostics Laboratory at Oregon Health Sciences University and founding member of the Oregon DNA Forensic Experts Panel.

Mike Fannon, Founder and CEO of BioIT Solutions.

Mike Fannon currently advises new biotechnology firms in the areas of information technology and customer relationship management, business strategy, and laboratory automation. He is CEO of BioIT solutions, a leading company specializing in advanced computational, workflow, and data-management systems for clinical diagnostics, drug development, and biotechnology research. He was the chief architect of BioIT’s innovative 1Platform4 software and was the former Vice President and Chief Information Officer at Human Genome Sciences, where he and his team developed computerized solutions to manage Human Genome Sciences’ R&D functions, high-volume labs, product development, and clinical trials. Mr. Fannon holds an MBA in Operations Analysis from American University and a Bachelors degree in Physics from Rollins College.